32.35MUSD
1.91
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US72940R3003
CUSIP
72940P106
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
June
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
1.18
Dividend Share
0
Dividend Yield
0.00%
Earnings Share
-1.462
Wall Street Target Price
3.50
EPS Estimate Current Year
-1.18
EPS Estimate Next Year
-1.25
EPS Estimate Current Quarter
-0.36
EPS Estimate Next Quarter
-0.38
Most Recent Quarter
-
Revenue TTM
234,000
Gross Profit TTM
23,000
EBITDA
-46,047,000
Profit Margin
0.00%
Return On Assets TTM
-37.35%
Return On Equity TTM
-86.55%
Revenue Per Share TTM
0.007
Qtly Revenue Growth YOY
-54.00%
Diluted Eps TTM
-1.462
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
3
Price Sales TTM
138.2376
Price Book MRQ
0.9256
Enterprise Value Revenue
17
Enterprise Value EBITDA
0
178.56
3.21%560.89
2.89%37.50
1.87%465.00
1.73%48.36
0.77%90.00
0.00%4.04
0.00%27.72
-6.26%85.10
-2.23%106.10
-1.27%